BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 8, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 14, 2011
View Archived Issues
New carbapenem antibiotics described
Read More
Irosustat demonstrates pharmacodynamic proof of concept
Read More
New DNA vaccine is efficacious in monkey model of tuberculosis
Read More
Gantenerumab reduces amyloid levels in brain
Read More
Scientists in U.K. identify microRNA biomarker in COPD
Read More
Phase I/II data disclosed on trabedersen in melanoma, pancreatic and colorectal carcinoma
Read More
Intellikine advances first-in-human trial of INK-1117
Read More
Ironwood Pharmaceuticals prepares new GCS activators
Read More
Isis Pharmaceuticals selects second development candidate in GlaxoSmithKline collaboration
Read More
Dainippon Sumitomo Pharma discloses novel agents for sepsis
Read More
ISCO reports promising preclinical results with hpSC-derived neuronal cells
Read More
New deuterated dimethylcurcumin derivatives claimed by Concert Pharmaceuticals
Read More
Scientists at Gilead Sciences patent new SYK inhibitors
Read More
Novel histamine receptor antagonists presented by Kalypsys
Read More
Medicago completes first stage of noninfluenza VLP vaccine collaboration agreement
Read More
Michael J. Fox Foundation funds clinical study of Parkinson's disease vaccine
Read More
ISTA provides update on development of bromfenac ophthalmic solutions
Read More
Topline data reported from Pozen's phase III PA-32540 study
Read More
FDA grants pre-IND meeting to Advaxis for ADXS-HER2
Read More
DSMB recommends continuing Cyclacel's SEAMLESS trial
Read More
Micromet outlines registration strategy for blinatumomab
Read More
Kissei Pharmaceutical to pay MediciNova for further development of MN-221
Read More
Baxter International starts phase III trial of recombinant von Willebrand factor
Read More
FDA committee recommends approval of Zilver PTX paclitaxel-eluting stent
Read More
Telik commences phase IIb trial of Telintra
Read More